The pharmaceutical industry racked up some of the high-highs and low-lows of the IndustryWeek 500. Some of that drama was just a function of the balance sheet, as companies spun off parts of their businesses or made acquisitions.
Top performer Johnson & Johnson for instance, clocking in at No. 1 in the pharmaceuticals category, saw solid revenue growth of 4.3% but racked up a 60% loss in net income as it spun off its over-the-counter medications and consumer products into a new company, Kenvue. Merck grew exponentially in 2024 after the 2023 purchase of a company that makes a newly FDA-approved type of schizophrenia drug.
Click through the slideshow to read more about the top pharmaceutical companies in this year’s IW 500.
Voice your opinion!
Voice your opinion!
To join the conversation, and become an exclusive member of IndustryWeek, create an account today!
Sponsored
Sponsored